A ‘revolutionary’ blood test which can detect breast cancer relapses nearly eight months before they strike has been developed by the British scientists.
The test, created by the Institute of Cancer Research, in London can detect small numbers of residual cancer cells that have resisted therapy by looking for tumour DNA in the bloodstream.
The researchers say it is an important step towards the use of ‘Liquid biopsies’ to revolutionary breast cancer care in changing the way cancer is monitored and helping doctors decide on the best treatment.
